Pharscin Pharma
00290712.762.41% ( +0.30 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Pharscin Pharma(002907) the Revenue is 211.85 M (-11.34%);the EBIT is 30.43 M (-32.98%);the EPS is 0.0785 (-18.74%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.21B11.34%
----
----
EBIT
0.03B32.98%
----
----
EPS
0.078518.74%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf